DLGAP5 mutation was found in 6% of TCGA endometrial cancer samples, and the somatic mutation frequency accounted for 5.9%, most of which are missense mutations and relatively dispersed (Fig. 8). The gene discussed is DLGAP5; the disease is endometrial cancer.